Joint modeling of longitudinal and time‐to‐event data for dynamic disease risk prediction using proteomics

dc.contributor.authorLindén, Markus
dc.contributor.authorAmmunét, Tea
dc.contributor.authorVälikangas, Tommi
dc.contributor.authorElo, Laura L.
dc.contributor.authorSuomi, Tomi
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=Turun biotiedekeskus|en=Turku Bioscience Centre|
dc.contributor.organizationfi=InFLAMES Lippulaiva|en=InFLAMES Flagship|
dc.contributor.organization-code1.2.246.10.2458963.20.18586209670
dc.contributor.organization-code1.2.246.10.2458963.20.68445910604
dc.converis.publication-id526456075
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/526456075
dc.date.accessioned2026-06-10T20:11:35Z
dc.description.abstract<p>Biomedical studies increasingly incorporate longitudinal data, enabling us to track individual disease processes over time at the molecular level, and to discover associations of the molecular profiles with the outcome of interest, such as the onset of a disease. Despite the potential of statistical methods that jointly model longitudinal and time-to-event data, they have not yet been widely adopted in high-throughput omics studies. Therefore, we evaluated multiple approaches for joint modeling of longitudinal and time-to-event data, and we introduce a joint modeling strategy for longitudinal proteomics studies. The focus is on assessing the utility of the methods in predicting the dynamic disease risk of an individual from longitudinal proteome profiles. To benchmark the methods, we used a range of simulated datasets that reflected real proteome profiles with varying complexities. Our results clearly demonstrated the advantages of the longitudinal methods over conventional Cox proportional hazards models with single time point studies. This was further supported by re-analysis of data from a proteomics study of early type 1 diabetes prediction, where we discovered new early candidate proteins associated with the disease onset that were not detected in the original study.<br></p>
dc.identifier.eissn1469-896X
dc.identifier.jour-issn0961-8368
dc.identifier.urihttps://www.utupub.fi/handle/11111/61685
dc.identifier.urlhttps://doi.org/10.1002/pro.70621
dc.identifier.urnURN:NBN:fi-fe2026060865229
dc.language.isoen
dc.okm.affiliatedauthorLinden, Markus
dc.okm.affiliatedauthorElo, Laura
dc.okm.affiliatedauthorSuomi, Tomi
dc.okm.affiliatedauthorDataimport, Biolääketieteen laitoksen yhteiset
dc.okm.discipline318 Medical biotechnologyen_GB
dc.okm.discipline318 Lääketieteen bioteknologiafi_FI
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherWiley
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.articlenumbere70621
dc.relation.doi10.1002/pro.70621
dc.relation.ispartofjournalProtein Science
dc.relation.issue6
dc.relation.volume35
dc.titleJoint modeling of longitudinal and time‐to‐event data for dynamic disease risk prediction using proteomics
dc.year.issued2026

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
Protein Science - 2026 - Lindén - Joint modeling of longitudinal and time‐to‐event data for dynamic disease risk prediction.pdf
Size:
1.82 MB
Format:
Adobe Portable Document Format